L&S Knock-Out MRK 12.06.2024/ DE000LX3SGU8 /
31/05/2024 15:02:50 | Chg.+0.01 | Bid15:02:50 | Ask15:02:50 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.25EUR | +4.17% | 0.25 Bid Size: - |
0.26 Ask Size: - |
MERCK KGAA O.N. | 140.00 EUR | 12/06/2024 | Call |
GlobeNewswire
29/05
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
07/05
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
06/05
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
04/03
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
21/12/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
14/12/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
17/10/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA